HighMark Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04K | Sell |
59
-2
| -3% | -$137 | ﹤0.01% | 420 |
|
|
2025
Q1 | $4.25K | Buy |
61
+5
| +9% | +$348 | ﹤0.01% | 386 |
|
|
2024
Q4 | $4.83K | Buy |
56
+8
| +17% | +$690 | ﹤0.01% | 385 |
|
|
2024
Q3 | $5.73K | Buy |
48
+13
| +37% | +$1.55K | ﹤0.01% | 388 |
|
|
2024
Q2 | $5.01K | Buy |
35
+8
| +30% | +$1.14K | ﹤0.01% | 388 |
|
|
2024
Q1 | $3.47K | Buy |
+27
| New | +$3.47K | ﹤0.01% | 407 |
|
|
2023
Q4 | – | Sell |
-36
| Closed | -$3.27K | – | 596 |
|
|
2023
Q3 | $3.27K | Sell |
36
-4
| -10% | -$364 | ﹤0.01% | 400 |
|
|
2023
Q2 | $3.56K | Sell |
40
-26
| -39% | -$2.31K | ﹤0.01% | 397 |
|
|
2023
Q1 | $5.25K | Sell |
66
-74
| -53% | -$5.89K | ﹤0.01% | 388 |
|
|
2022
Q4 | $9.47K | Buy |
140
+32
| +30% | +$2.17K | 0.01% | 264 |
|
|
2022
Q3 | $5K | Buy |
+108
| New | +$5K | ﹤0.01% | 338 |
|